Cardio-Oncology

Explore how to mitigate the effects of cancer on the heart.

Science News

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science
2024 Guideline for the Primary Prevention of Stroke
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship
Heart Disease and Stroke Statistics - 2024 Update
Cardiovascular Imaging in Contemporary Cardio-Oncology

Journals

Reducing Granules Without Splicing Restoration Alleviates RBM20 Cardiomyopathy
Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial
Novel Truncated Peptide Derived From circCDYL Exacerbates Cardiac Hypertrophy
Burden of Congenital Heart Anomalies in North Africa and the Middle East, 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021
Stroke Outcomes in a Population‐Focused Urban Hypertension Program in Brazil and Senegal
Audience members listen to a presentation during Scientific Sessions 2022 in Chicago, Illinois. Mark your calendar

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content. We can't wait to see you November 2023!

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

CEO Nancy Brown on Cardio Oncology

CEO Nancy Brown explains why the AHA is funding a Strategically Focused Research Network on cardio-oncology with $15 million and, working with CancerLinQ LLC, making oncology datasets available on a version of the Precision Medicine Platform.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership